Free Trial

Immix Biopharma (IMMX) SEC Filings & 10K Form

Immix Biopharma logo
$1.96 -0.04 (-2.00%)
As of 02:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Immix Biopharma SEC Filings

DateFilerForm TypeView
08/08/2025
4:28 PM
Immix Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2025
8:35 AM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
8:35 AM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
2:00 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
2:05 PM
Immix Biopharma (Filer)
Form 424B5
05/19/2025
4:19 PM
Immix Biopharma (Filer)
Form 10-K/A
05/19/2025
4:21 PM
Immix Biopharma (Filer)
Form DEFA14A
05/19/2025
4:23 PM
Immix Biopharma (Filer)
Form 10-Q/A
05/19/2025
4:25 PM
Immix Biopharma (Filer)
Form ARS
05/08/2025
3:30 PM
Immix Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/29/2025
5:17 AM
HIRSCHMAN ORIN (Filed by)
Immix Biopharma (Subject)
Form SCHEDULE 13G/A
12/26/2024
3:20 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMMX) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners